Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 318

1.

Vaccination with recombinant RNA replicon particles protects chickens from H5N1 highly pathogenic avian influenza virus.

Halbherr SJ, Brostoff T, Tippenhauer M, Locher S, Berger Rentsch M, Zimmer G.

PLoS One. 2013 Jun 10;8(6):e66059. doi: 10.1371/journal.pone.0066059. Print 2013.

2.

A recombinant vesicular stomatitis virus replicon vaccine protects chickens from highly pathogenic avian influenza virus (H7N1).

Kalhoro NH, Veits J, Rautenschlein S, Zimmer G.

Vaccine. 2009 Feb 18;27(8):1174-83. doi: 10.1016/j.vaccine.2008.12.019. Epub 2009 Jan 7.

PMID:
19135116
3.

Comparative efficacy of North American and antigenically matched reverse genetics derived H5N9 DIVA marker vaccines against highly pathogenic Asian H5N1 avian influenza viruses in chickens.

Jadhao SJ, Lee CW, Sylte M, Suarez DL.

Vaccine. 2009 Oct 19;27(44):6247-60. doi: 10.1016/j.vaccine.2009.07.110. Epub 2009 Aug 15.

PMID:
19686695
4.

Protection of chickens against H5N1 highly pathogenic avian influenza virus infection by live vaccination with infectious laryngotracheitis virus recombinants expressing H5 hemagglutinin and N1 neuraminidase.

Pavlova SP, Veits J, Keil GM, Mettenleiter TC, Fuchs W.

Vaccine. 2009 Jan 29;27(5):773-85. doi: 10.1016/j.vaccine.2008.11.033. Epub 2008 Nov 28.

PMID:
19041677
5.

Protective efficacy of Newcastle disease virus expressing soluble trimeric hemagglutinin against highly pathogenic H5N1 influenza in chickens and mice.

Cornelissen LA, de Leeuw OS, Tacken MG, Klos HC, de Vries RP, de Boer-Luijtze EA, van Zoelen-Bos DJ, Rigter A, Rottier PJ, Moormann RJ, de Haan CA.

PLoS One. 2012;7(8):e44447. doi: 10.1371/journal.pone.0044447. Epub 2012 Aug 28.

6.

Live vaccination with an H5-hemagglutinin-expressing infectious laryngotracheitis virus recombinant protects chickens against different highly pathogenic avian influenza viruses of the H5 subtype.

Pavlova SP, Veits J, Mettenleiter TC, Fuchs W.

Vaccine. 2009 Aug 13;27(37):5085-90. doi: 10.1016/j.vaccine.2009.06.048. Epub 2009 Jun 30.

PMID:
19573638
7.

Protective efficacy of several vaccines against highly pathogenic H5N1 avian influenza virus under experimental conditions.

Veits J, Römer-Oberdörfer A, Helferich D, Durban M, Suezer Y, Sutter G, Mettenleiter TC.

Vaccine. 2008 Mar 20;26(13):1688-96. doi: 10.1016/j.vaccine.2008.01.016. Epub 2008 Feb 4.

PMID:
18291561
8.

Experimental challenge of chicken vaccinated with commercially available H5 vaccines reveals loss of protection to some highly pathogenic avian influenza H5N1 strains circulating in Hong Kong/China.

Connie Leung YH, Luk G, Sia SF, Wu YO, Ho CK, Chow KC, Tang SC, Guan Y, Malik Peiris JS.

Vaccine. 2013 Aug 2;31(35):3536-42. doi: 10.1016/j.vaccine.2013.05.076. Epub 2013 Jun 19.

PMID:
23791547
9.

Vaccine protection of chickens against antigenically diverse H5 highly pathogenic avian influenza isolates with a live HVT vector vaccine expressing the influenza hemagglutinin gene derived from a clade 2.2 avian influenza virus.

Kapczynski DR, Esaki M, Dorsey KM, Jiang H, Jackwood M, Moraes M, Gardin Y.

Vaccine. 2015 Feb 25;33(9):1197-205. doi: 10.1016/j.vaccine.2014.12.028. Epub 2015 Jan 20.

10.

Level of protection of chickens against highly pathogenic H5 avian influenza virus with Newcastle disease virus based live attenuated vector vaccine depends on homology of H5 sequence between vaccine and challenge virus.

Römer-Oberdörfer A, Veits J, Helferich D, Mettenleiter TC.

Vaccine. 2008 May 2;26(19):2307-13. doi: 10.1016/j.vaccine.2008.02.061. Epub 2008 Mar 18.

PMID:
18395947
11.

Vaccine Efficacy of Inactivated, Chimeric Hemagglutinin H9/H5N2 Avian Influenza Virus and Its Suitability for the Marker Vaccine Strategy.

Kim SM, Kim YI, Park SJ, Kim EH, Kwon HI, Si YJ, Lee IW, Song MS, Choi YK.

J Virol. 2017 Feb 28;91(6). pii: e01693-16. doi: 10.1128/JVI.01693-16. Print 2017 Mar 15.

PMID:
28077631
12.

Immunization with plant-expressed hemagglutinin protects chickens from lethal highly pathogenic avian influenza virus H5N1 challenge infection.

Kalthoff D, Giritch A, Geisler K, Bettmann U, Klimyuk V, Hehnen HR, Gleba Y, Beer M.

J Virol. 2010 Nov;84(22):12002-10. doi: 10.1128/JVI.00940-10. Epub 2010 Sep 1.

13.

Newcastle disease virus-based live attenuated vaccine completely protects chickens and mice from lethal challenge of homologous and heterologous H5N1 avian influenza viruses.

Ge J, Deng G, Wen Z, Tian G, Wang Y, Shi J, Wang X, Li Y, Hu S, Jiang Y, Yang C, Yu K, Bu Z, Chen H.

J Virol. 2007 Jan;81(1):150-8. Epub 2006 Oct 18.

14.

Prime-boost vaccination with recombinant H5-fowlpox and Newcastle disease virus vectors affords lasting protection in SPF Muscovy ducks against highly pathogenic H5N1 influenza virus.

Niqueux E, Guionie O, Amelot M, Jestin V.

Vaccine. 2013 Aug 28;31(38):4121-8. doi: 10.1016/j.vaccine.2013.06.074. Epub 2013 Jul 8.

PMID:
23845804
15.

Expression of H5 hemagglutinin vaccine antigen in common duckweed (Lemna minor) protects against H5N1 high pathogenicity avian influenza virus challenge in immunized chickens.

Bertran K, Thomas C, Guo X, Bublot M, Pritchard N, Regan JT, Cox KM, Gasdaska JR, Dickey LF, Kapczynski DR, Swayne DE.

Vaccine. 2015 Jul 9;33(30):3456-62. doi: 10.1016/j.vaccine.2015.05.076. Epub 2015 Jun 9.

PMID:
26067184
16.

Protective efficacy of baculovirus-derived influenza virus-like particles bearing H5 HA alone or in combination with M1 in chickens.

Choi JG, Kim MC, Kang HM, Kim KI, Lee KJ, Park CK, Kwon JH, Kim JH, Lee YJ.

Vet Microbiol. 2013 Mar 23;162(2-4):623-30. doi: 10.1016/j.vetmic.2012.11.035. Epub 2012 Nov 29.

PMID:
23265240
17.

Highly pathogenic avian influenza virus H5N1 from Egypt escapes vaccine-induced immunity but confers clinical protection against a heterologous clade 2.2.1 Egyptian isolate.

Grund C, Abdelwhab el-SM, Arafa AS, Ziller M, Hassan MK, Aly MM, Hafez HM, Harder TC, Beer M.

Vaccine. 2011 Jul 26;29(33):5567-73. doi: 10.1016/j.vaccine.2011.01.006. Epub 2011 Jan 15.

PMID:
21244859
18.

New DIVA vaccine for the protection of poultry against H5 highly pathogenic avian influenza viruses irrespective of the N-subtype.

Peeters B, de Boer SM, Tjeerdsma G, Moormann R, Koch G.

Vaccine. 2012 Nov 19;30(49):7078-83. doi: 10.1016/j.vaccine.2012.09.050. Epub 2012 Oct 2.

PMID:
23036502
19.

Efficacy of a Recombinant Turkey Herpesvirus H5 Vaccine Against Challenge With H5N1 Clades 1.1.2 and 2.3.2.1 Highly Pathogenic Avian Influenza Viruses in Domestic Ducks (Anas platyrhynchos domesticus).

Pantin-Jackwood MJ, Kapczynski DR, DeJesus E, Costa-Hurtado M, Dauphin G, Tripodi A, Dunn JR, Swayne DE.

Avian Dis. 2016 Mar;60(1):22-32. doi: 10.1637/11282-091615-Reg.1.

PMID:
26953940
20.

Generation of an attenuated H5N1 avian influenza virus vaccine with all eight genes from avian viruses.

Shi H, Liu XF, Zhang X, Chen S, Sun L, Lu J.

Vaccine. 2007 Oct 16;25(42):7379-84. Epub 2007 Aug 24.

PMID:
17870216

Supplemental Content

Support Center